Completed
NCT Number: NCT04446052
Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia
Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia
Completed
Looking for future studies?
Notify MeKey information
Age range
56 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All patients with acute non-lymphocytic leukemia are eligible for the study.
Exclusion criteria
- N/A
Treatment and study plan
Placebo
DrugPlacebo
Primary outcomes
-
complete remission rates
Time frame: 3 years
Sponsors and collaborators
Lead sponsor
Eastern Cooperative Oncology Group
Network
Registry information
Official study title
Phase III Study Priming With rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and Over) With Acute Non-Lymphocytic Leukemia
Important dates
- Study start
- 1993
- Primary completion
- 2002
- Study completion
- 2002
- First posted
- Jun 24, 2020
- Registry last updated
- Jun 22, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.